Do you want to read an article? Please log in or register.
Early and Late C-peptide Responses during Oral Glucose Tolerance Testing are Oppositely Predictive of Type 1 Diabetes in Autoantibody Positive Individuals
Type 1 Diabetes
Related content
COMMENTED
Type 1 Diabetes
C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Bogun MM, Bundy BN, Goland RS, Greenbaum CJ
doi: 10.2337/dc19-2288.
Type 2 Diabetes
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
Diabetes Care
Ahuja V, Aronen P, Pramodkumar TA, Looker H, Chetrit A, Bloigu AH, Juutilainen A, Bianchi C, La Sala L, Anjana RM, Pradeepa R, Venkatesan U, Jebarani S, Baskar V, Fiorentino TV, Timpel P, DeFronzo RA, Ceriello A, Del Prato S, Abdul-Ghani M, Keinänen-Kiukaanniemi S, Dankner R, Bennett PH, Knowler WC, Schwarz P, Sesti G, Oka R, Mohan V, Groop L, Tuomilehto J, Ripatti S, Bergman M, Tuomi T
doi: 10.2337/dc20-1688
COMMENTED
Type 2 Diabetes
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Diabetes Care.
Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG
doi: 10.2337/dc18-0431.
COMMENTED
Diabetes - GeneralType 1 Diabetes
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial
JAMA.
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer JP, Schatz DA, Bundy B, Skyler JS, Greenbaum CJ
doi: 10.1001/
COMMENTED
Type 1 DiabetesPediatric Diabetes
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetologia.
Jacobsen LM, Bocchino L, Evans-Molina C, DiMeglio L, Goland R, Wilson DM, Atkinson MA, Aye T, Russell WE, Wentworth JM, Boulware D, Geyer S, Sosenko JM
doi: 10.1007/s00125-019-05047-w.
COMMENTED
Diabetes - GeneralType 1 DiabetesType 2 DiabetesGlycemic Control
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
doi: 10.1007/s00125-017-4449-2.
RECOMMENDED
Type 1 Diabetes
Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes
doi: 10.2337/dc18-0861.
Type 1 Diabetes
Adherence to Oral Glucose Tolerance Testing in Children in Stage 1 of Type 1 Diabetes: the TEDDY Study
Pediatr Diabetes
Driscoll KA, Tamura R, Johnson SB, Gesualdo P, Clasen RNJ, Smith L, Jacobsen L, Larsson HE, Haller MJ, TEDDY Study Group.
doi: 10.1111/pedi.13149
Diabetes and Pregnancy
Oral Glucose Tolerance Test Results in Pregnancy Can Be Used to Individualize the Risk of Future Maternal Type 2 Diabetes Mellitus in Women With Gestational Diabetes Mellitus
Diabetes Care
Hiersch L, Shah BR, Berger H, Geary M, McDonald SD, Murray-Davis B, Halperin I, Retnakaran R, Barrett J, Melamed N, for DOH-NET (Diabetes, Obesity and Hypertension in Pregnancy Research Network) and SOON (Southern Ontario Obstetrical Network) investigators.
doi: 10.2337/dc21-0659